Cornerstone Research Group Inc.

Cornerstone Research Group Inc. specializes in delivering advanced analytical solutions and consulting services to the healthcare sector, primarily focusing on health economics and outcomes research to improve patient outcomes. Founded in 2005 and headquartered in Burlington, Canada, Cornerstone Research Group Inc. focuses on providing analytical solutions to the healthcare industry.

The company was acquired by Eversana Life Science Services LLC in October 2019, which was completed in November 2019, although the financial terms were not disclosed. The company has been involved in a total of 1 deal, with the most recent deal occurring on October 30, 2019. Cornerstone Research Group Inc. offers a comprehensive suite of services centered around Health Economics and Outcomes Research (HEOR).

Their offerings include the development of a Value & Evidence Platform, assisting clients in creating product value narratives, evidence development strategies, and reimbursement submissions. They cater to a diverse clientele encompassing major pharmaceutical firms, medical device manufacturers, and innovative biotechnology companies across various therapeutic areas including oncology, cardiovascular, and rare diseases, providing solutions focused on global market access in North America, Europe, and Asia. The revenue model of Cornerstone Research Group Inc. is structured around B2B partnerships and tailored service agreements with clients in the healthcare sector.

The company engages in transactions involving long-term contracts for HEOR services, including strategic consulting and data analysis. While specific pricing for services is not publicly disclosed, their offerings aim to provide substantial value in securing reimbursement and demonstrating clinical benefits, encompassing integrated commercialization solutions, market access strategies, and analytics-driven insights. Looking ahead, Cornerstone Research Group Inc. aims to enhance its service offerings and expand its market presence following the acquisition by Eversana.

While specific upcoming product launches have not been detailed, the company is expected to leverage resources and expertise to develop innovative solutions for the healthcare market. The acquisition will facilitate entry into new geographic regions and allow for an increased focus on global market access strategies, targeting expansion efforts in North America, Europe, and Asia. The recent acquisition is anticipated to significantly support these initiatives, reinforcing their strategic objectives.